← Eichor
Study identifier: NCT04212910 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model

Condition: Endometrium Cancer  ·  Sponsor: IRCCS San Raffaele

PhaseN/A
Planned participants101
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

Endometrial cancer (EC) is the most common gynecological malignancy in high-income countries. Prognosis and treatment are dictated by cancer histological subtype and grade coupled with surgical staging as described by Surgical International Federation of Gynecology and Obstetrics (FIGO) staging system. Surgery is the elective standard treatment and used for staging of EC. The purpose of this study is to collect images from a simultaneous PET/MRI study from which to extrapolate a preoperative, non-invasive, prognostic model.

This description comes directly from the study's public registry record.

Talk to the study team

Stephanie Steidler, PhD  ·  +39022643  ·  steidler.stephanie@hsr.it

Always discuss trial participation with your own doctor first.

Locations (1)

IRCCS Ospedale San RaffaeleMilan, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04212910